Tags

Type your tag names separated by a space and hit enter

Sexually Transmitted Infections Part 2: Discharge Syndromes and Pelvic Inflammatory Disease.
Pediatr Rev. 2020 Oct; 41(10):522-537.PR

Abstract

Sexually transmitted infections (STIs) disproportionately affect young people, with more than half of the infections occurring in youth aged 15 to 25 years. (1)(2) This review, the second in a 2-part series on STIs, focuses on infections that may cause abnormal vaginal or penile discharge, including trichomonas, chlamydia, gonorrhea, and pelvic inflammatory disease (PID). Most infected persons, however, are asymptomatic. Nucleic acid amplification tests are the most sensitive and specific for the detection of chlamydia, gonorrhea, and trichomoniasis, and they can be performed on provider- or patient-collected swabs. Providers should have a low threshold for diagnosing and treating PID because untreated PID can have serious long-term complications for young women. Indications for hospitalization for PID include the presence of a tubo-ovarian abscess, severe illness with systemic symptoms, pregnancy, human immunodeficiency virus infection, and failure to respond to outpatient oral treatment (within 48-72 hours) or inability to tolerate the oral treatment.

Authors+Show Affiliations

Division of Adolescent and Young Adult Medicine and. Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA. Harvard Medical School, Boston, MA.Division of Adolescent and Young Adult Medicine and. Division of Global Health, MassGeneral Hospital for Children, Boston, MA. Harvard Medical School, Boston, MA.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

33004664

Citation

Lemly, Diana, and Nupur Gupta. "Sexually Transmitted Infections Part 2: Discharge Syndromes and Pelvic Inflammatory Disease." Pediatrics in Review, vol. 41, no. 10, 2020, pp. 522-537.
Lemly D, Gupta N. Sexually Transmitted Infections Part 2: Discharge Syndromes and Pelvic Inflammatory Disease. Pediatr Rev. 2020;41(10):522-537.
Lemly, D., & Gupta, N. (2020). Sexually Transmitted Infections Part 2: Discharge Syndromes and Pelvic Inflammatory Disease. Pediatrics in Review, 41(10), 522-537. https://doi.org/10.1542/pir.2019-0078
Lemly D, Gupta N. Sexually Transmitted Infections Part 2: Discharge Syndromes and Pelvic Inflammatory Disease. Pediatr Rev. 2020;41(10):522-537. PubMed PMID: 33004664.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Sexually Transmitted Infections Part 2: Discharge Syndromes and Pelvic Inflammatory Disease. AU - Lemly,Diana, AU - Gupta,Nupur, PY - 2020/10/2/entrez PY - 2020/10/3/pubmed PY - 2020/11/25/medline SP - 522 EP - 537 JF - Pediatrics in review JO - Pediatr Rev VL - 41 IS - 10 N2 - Sexually transmitted infections (STIs) disproportionately affect young people, with more than half of the infections occurring in youth aged 15 to 25 years. (1)(2) This review, the second in a 2-part series on STIs, focuses on infections that may cause abnormal vaginal or penile discharge, including trichomonas, chlamydia, gonorrhea, and pelvic inflammatory disease (PID). Most infected persons, however, are asymptomatic. Nucleic acid amplification tests are the most sensitive and specific for the detection of chlamydia, gonorrhea, and trichomoniasis, and they can be performed on provider- or patient-collected swabs. Providers should have a low threshold for diagnosing and treating PID because untreated PID can have serious long-term complications for young women. Indications for hospitalization for PID include the presence of a tubo-ovarian abscess, severe illness with systemic symptoms, pregnancy, human immunodeficiency virus infection, and failure to respond to outpatient oral treatment (within 48-72 hours) or inability to tolerate the oral treatment. SN - 1526-3347 UR - https://www.unboundmedicine.com/medline/citation/33004664/Sexually_Transmitted_Infections_Part_2:_Discharge_Syndromes_and_Pelvic_Inflammatory_Disease. L2 - http://pedsinreview.aappublications.org/cgi/pmidlookup?view=long&pmid=33004664 DB - PRIME DP - Unbound Medicine ER -